Geitung JT. Editorial for "Potential Anti-Human Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer". J Magn Reson Imaging 2023 Feb 6. doi: 10.1002/jmri.28626.
PMID: 36744580